Sort
21,453 grants matching “tuberculosis”
Screening Complete TB Proteome for Protective Antigens
$879,258Alan Greener · Gene Therapy Systems, Inc. · R44 · FY2008 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$879,190Raymond T Chung · Massachusetts General Hospital · U19 · FY2021 · AI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine
$878,466Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · AI
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
$878,071Elliott Paul Dawson · Bioventures, Inc. · R42 · FY2017 · HG
Clinical Core
$877,948Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI
Clinical Trial Site Monitoring for PHOENIx MDR-TB
$877,923Kimberly Smith · Ppd Development Lp · N01 · FY2021 · AI
Multi-Drug Resistant Tuberculosis Drugs: Targeting Cell Wall Synthetic Enzymes
$877,762Michael R McNeil · Colorado State University · P01 · FY2007 · AI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
$877,748Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2021 · AI
ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS
$877,406Shabaana A. Khader · Washington University · R01 · FY2017 · AI
Spectinomycin analogs for NTM infections
$877,232Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Biology of lipoamide dehydrogenase and 2-hydroxy-3-oxoadipate synthase in Mtb
$876,693Carl F Nathan · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · AI
Innovative Approaches to Tuberculosis Control
$876,125Richard E Chaisson · Johns Hopkins University · U19 · FY2009 · AI
Viable but Nonculturable Mtb
$876,100Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2014 · AI
DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS
$876,066Texas Agrilife Research · P01 · FY2003 · AI
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
$875,813Satish Gopal · Univ Of North Carolina Chapel Hill · U54 · FY2017 · CA
Project 1: Transmission Biology of M. tuberculosis: Genes Required to Survive Stressful Transitions
$875,451Carl F Nathan · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Reagent Program for HIV and other Infectious Diseases
$874,178Sujatha Rashid · American Type Culture Collection · N01 · FY2024 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$873,826Joy Sennett · Mississippi State Department Of Health · U52 · FY2007 · PS
Safe Pregnancy by Infectious Disease Control in Kinshasa
$873,636Carl Bose · Univ Of North Carolina Chapel Hill · U01 · FY2006 · HD
Host and Microbial risk factors for drug-sensitive and resistant tuberculosis
$873,620Paul Edward Farmer · Brigham And Women'S Hospital · U19 · FY2007 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$873,515Chiyome L Fukino · Hawaii State Department Of Health · U52 · FY2008 · PS
Mycobacterium avium complex pulmonary infection: immunologic and transcriptomic signatures of disease and treatment response
$873,166Kevin Loring Winthrop · Oregon Health & Science University · R01 · FY2024 · AI
Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function
$873,043Deepak Kaushal · Tulane University Of Louisiana · R01 · FY2017 · AI
Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease
$872,777Thomas Dick · Hackensack University Medical Center · R01 · FY2025 · AI
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
$872,386Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2014 · DE